Felzartamab
MOR202C206
Phase 2 small_molecule completed
Quick answer
Felzartamab for Immunoglobulin A (IgA) Nephropathy is a Phase 2 program (small_molecule) at Biogen with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Biogen
- Indication
- Immunoglobulin A (IgA) Nephropathy
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed